Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJNYSE:JPM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$163.63+0.3%$158.68$140.68▼$169.99$394.32B0.477.63 million shs5.76 million shsJPMJPMorgan Chase & Co.$242.97-2.1%$257.55$179.20▼$280.25$679.36B1.19.34 million shs11.98 million shsUnlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson+0.97%+0.18%-1.75%+12.52%+3.33%JPMJPMorgan Chase & Co.-1.05%+3.97%-3.50%+2.98%+24.47%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationJNJJohnson & Johnson4.4036 of 5 stars2.33.04.23.93.52.50.6JPMJPMorgan Chase & Co.4.7737 of 5 stars2.35.04.22.13.42.52.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.56Moderate Buy$171.334.71% UpsideJPMJPMorgan Chase & Co. 2.53Moderate Buy$252.894.08% UpsideCurrent Analyst Ratings BreakdownLatest JNJ and JPM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/10/2025JNJJohnson & JohnsonGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral3/7/2025JPMJPMorgan Chase & Co.Baird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong Sell ➝ Hold3/7/2025JPMJPMorgan Chase & Co.Robert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderperform ➝ Neutral$215.00 ➝ $220.003/5/2025JNJJohnson & JohnsonBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.002/19/2025JNJJohnson & JohnsonRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.002/3/2025JNJJohnson & JohnsonGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$162.00 ➝ $166.001/28/2025JNJJohnson & JohnsonBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$159.00 ➝ $166.001/24/2025JNJJohnson & JohnsonArgusSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy1/23/2025JNJJohnson & JohnsonRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.001/23/2025JNJJohnson & JohnsonMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$175.00 ➝ $163.001/23/2025JNJJohnson & JohnsonLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$182.00 ➝ $169.00(Data available from 3/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$88.82B4.44$13.45 per share12.17$29.69 per share5.51JPMJPMorgan Chase & Co.$169.44B4.01$20.05 per share12.12$116.13 per share2.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$6.6524.6114.782.5618.20%34.24%13.63%4/15/2025 (Estimated)JPMJPMorgan Chase & Co.$58.47B$19.7412.3112.512.8320.96%16.99%1.31%4/11/2025 (Estimated)Latest JNJ and JPM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/15/2025N/AJNJJohnson & Johnson$2.59N/AN/AN/A$21.65 billionN/A4/11/2025N/AJPMJPMorgan Chase & Co.$4.57N/AN/AN/A$43.62 billionN/A1/22/2025Q4 2024JNJJohnson & Johnson$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion1/15/2025Q4 2024JPMJPMorgan Chase & Co.$4.03$4.81+$0.78$4.81$41.90 billion$42.77 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$4.963.03%+5.43%74.59%63 YearsJPMJPMorgan Chase & Co.$5.602.30%+8.10%28.37%15 YearsLatest JNJ and JPM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/18/2025JPMJPMorgan Chase & Co.quarterly$1.402.38%4/4/20254/4/20254/30/20251/2/2025JNJJohnson & Johnsonquarterly$1.243.43%2/18/20252/18/20253/4/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.431.110.86JPMJPMorgan Chase & Co.1.240.880.89Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%JPMJPMorgan Chase & Co.71.55%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%JPMJPMorgan Chase & Co.0.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson152,7002.41 billion2.40 billionOptionableJPMJPMorgan Chase & Co.293,7002.80 billion2.77 billionOptionableJNJ and JPM HeadlinesRecent News About These CompaniesFinancial Crime Weekly: Charlie Javice Convicted Of Fraud In JPMorgan Acquisition Case, Man Sentenced To 15 Years For Investment FraudMarch 28 at 5:52 PM | benzinga.comCharlie Javice, accused of misleading JPMorgan with fake users, found guilty of fraudMarch 28 at 5:07 PM | seekingalpha.comTSM Stock Under Pressure From Tariff Concerns, But Analysts Stay Bullish March 28 at 5:07 PM | talkmarkets.comCharlie Javice Found Guilty of Fraud Involving JPMorgan (JPM) AcquisitionMarch 28 at 5:07 PM | gurufocus.comCharlie Javice Found Guilty of Defrauding JPMorgan of $175 Million - The New York TimesMarch 28 at 4:42 PM | news.google.comJP Morgan's Stock Picks In The Power Sector Amid Regulatory UncertaintyMarch 28 at 4:07 PM | benzinga.comJury rules startup founder Charlie Javice guilty of defrauding JPMorgan ChaseMarch 28 at 3:42 PM | fortune.comStartup founder Charlie Javice found guilty of defrauding JPMorgan Chase in $175 million dealMarch 28 at 3:32 PM | cnbc.comCharlie Javice Found Guilty of Defrauding JPMorgan in $175 Million AcquisitionMarch 28 at 3:22 PM | nytimes.comCharlie Javice, founder of startup bought by JPMorgan, found guilty at fraud trial March 28 at 3:22 PM | investing.comCharlie Javice convicted of defrauding JPMorgan during $175 million sale of financial aid startupMarch 28 at 3:22 PM | financialpost.comCharlie Javice convicted of defrauding JPMorgan during $175 million sale of financial aid startupMarch 28 at 3:02 PM | marketbeat.comCharlie Javice convicted of defrauding JPMorgan during the $175 million sale of financial aid startup FrankMarch 28 at 3:00 PM | marketbeat.comJPMorgan Chase & Co. (NYSE:JPM) Trading Down 1.9% - Should You Sell?March 28 at 2:56 PM | marketbeat.comJPMorgan: The 'NVIDIA of Banking' Poised for More Gains?March 28 at 10:48 AM | marketbeat.comCrowdStrike Holdings: Strategic Growth and Optimistic Outlook Drive Buy RatingMarch 28 at 6:28 AM | tipranks.comJPMorgan Reduces Stake in Paladin EnergyMarch 28 at 5:41 AM | tipranks.comJPMorgan Chase & Co. (NYSE:JPM) Stock Position Reduced by Garland Capital Management Inc.March 28 at 4:09 AM | marketbeat.com4,706 Shares in JPMorgan Chase & Co. (NYSE:JPM) Acquired by ZEGA Investments LLCMarch 28 at 4:09 AM | marketbeat.comJPMorgan Chase & Co. (NYSE:JPM) Stock Position Lowered by Washington Trust BankMarch 28 at 4:09 AM | marketbeat.comWayfinding Financial LLC Makes New $1.19 Million Investment in JPMorgan Chase & Co. (NYSE:JPM)March 28 at 4:09 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockNVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBy Thomas Hughes | March 12, 2025View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy4 Stocks Raising Dividends by More Than 10%By Leo Miller | March 25, 2025View 4 Stocks Raising Dividends by More Than 10%Resilient Investing: 3 Stocks Built to Weather Market VolatilityBy Jeffrey Neal Johnson | March 17, 2025View Resilient Investing: 3 Stocks Built to Weather Market VolatilityJPMorgan: The 'NVIDIA of Banking' Poised for More Gains?By Gabriel Osorio-Mazilli | March 28, 2025View JPMorgan: The 'NVIDIA of Banking' Poised for More Gains?JNJ and JPM Company DescriptionsJohnson & Johnson NYSE:JNJ$163.63 +0.50 (+0.31%) Closing price 03:59 PM EasternExtended Trading$163.36 -0.27 (-0.17%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.JPMorgan Chase & Co. NYSE:JPM$242.96 -5.16 (-2.08%) Closing price 03:59 PM EasternExtended Trading$242.35 -0.62 (-0.25%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas JPMorgan: The 'NVIDIA of Banking' Poised for More Gains? Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback Joby Aviation Stock: Analyst Confidence and Smart Money Align Ibotta Stock: Why the Buyback Looks Like a Bullish Bet Archer Aviation Stock Sees Surge in Institutional Buys How Can Tomahawk 6 Contribute to Broadcom's AI Growth Story? Microsoft’s Big Malaysia Bet Could Pay Off for Investors Intuitive Machines Gains After Earnings Beat, NASA Missions Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
